OA05.03 Safety and Clinical Activity of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes (TIL) Combined With Nivolumab in NSCLC
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.259
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV